Gene · 4782
Papers1,961
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,961
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer. | Cancers (Basel) | 2023 | 36900162 | PubTator, text mining | PubMed |
| CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. | Cell Discov | 2023 | 36878933 | PubTator, text mining | PubMed |
| Proteolysis of CD44 at the cell surface controls a downstream protease network. | Front Mol Biosci | 2023 | 36876041 | PubTator, text mining | PubMed |
| Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer's disease. | Front Genet | 2023 | 36845373 | PubTator, text mining | PubMed |
| Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers. | Int J Mol Sci | 2023 | 36834728 | PubTator, text mining | PubMed |
| Advances in Autism Research: Series II. | Brain Sci | 2023 | 36831875 | PubTator, text mining | PubMed |
| The Future of Precision Medicine in the Cure of Alzheimer's Disease. | Biomedicines | 2023 | 36830872 | PubTator, text mining | PubMed |
| Cell-specific expression of the FAP gene is regulated by enhancer elements. | Front Mol Biosci | 2023 | 36825204 | PubTator, text mining | PubMed |
| New Insight Into Mechanisms of Hepatic Encephalopathy: An Integrative Analysis Approach to Identify Molecular Markers and Therapeutic Targets. | Bioinform Biol Insights | 2023 | 36814683 | PubTator, text mining | PubMed |
| In silico discovery of small molecules for efficient stem cell differentiation into definitive endoderm. | Stem Cell Reports | 2023 | 36801003 | PubTator, text mining | PubMed |
| Emerging roles of tRNA-derived fragments in cancer. | Mol Cancer | 2023 | 36782290 | PubTator, text mining | PubMed |
| Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study. | Clin Transl Med | 2023 | 36772945 | PubTator, text mining | PubMed |
| Genomic targets of the IRE1-XBP1s pathway in mediating metabolic adaptation in epithelial plasticity. | Nucleic Acids Res | 2023 | 36772828 | PubTator, text mining | PubMed |
| DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer. | Int J Mol Sci | 2023 | 36769317 | PubTator, text mining | PubMed |
| DNA methylation entropy is associated with DNA sequence features and developmental epigenetic divergence. | Nucleic Acids Res | 2023 | 36762477 | PubTator, text mining | PubMed |
| The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53. | Blood | 2023 | 36735909 | PubTator, text mining | PubMed |
| Deep learning predicts the impact of regulatory variants on cell-type-specific enhancers in the brain. | Bioinform Adv | 2023 | 36726730 | PubTator, text mining | PubMed |
| Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. | Br J Cancer | 2023 | 36725920 | PubTator, text mining | PubMed |
| Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells. | Oncogene | 2023 | 36725889 | PubTator, text mining | PubMed |
| Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators. | J Transl Med | 2023 | 36717859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4782/papers?page=16